论文信息 - Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control. - 字舞流文

Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control.

M. Thomas | A. Santoro | Tae-You Kim | L. Goff | C. Denlinger | J. Williams | F. Braud | C. Gallo-Stampino | E. Wang | P. Zucali | M. Simonelli | C. Noberasco | M. Carpentieri | P. English